Allen C. Ho,
Carl D. Regillo
Springer New York
e druk, 2016
9781493951147
Age-related Macular Degeneration Diagnosis and Treatment
Specificaties
Paperback, blz.
|
Engels
Springer New York |
2016
ISBN13: 9781493951147
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Age-Related Macular Degeneration: Diagnosis and Treatment is written by two leading experts from Wills Eye Hospital. Covering the latest therapies and treatments developed in the last few years, this is a concise yet highly illustrated and practical text that guides the clinician through diagnosis and treatment of the leading cause of blindness in older Americans.
Specificaties
ISBN13:9781493951147
Taal:Engels
Bindwijze:paperback
Uitgever:Springer New York
Inhoudsopgave
<p>Chapter 1<p>Genetics of Age-Related Macular Degeneration</p><p>Daniel Kasuga, Yuhong Chen, and Kang Zhang</p><p>Chapter 2</p><p>Modifiable Risk Factors of Age-Related Macular Degeneration</p><p>Hanna R. Coleman</p><p>Chapter 3</p><p>Diagnosis of Age-Related Macular Degeneration</p><p>Jon Jonisch and Gaurav Shah</p><p>Chapter 4</p><p>Fundus Imaging of Age-Related Macular Degeneration</p><p>Allen Chiang, Andre J. Witkin, Carl D. Regillo, and Allen C. Ho</p><p>Chapter 5</p><p>Therapy of Non-Exudative Age-Related Macular Degeneration</p><p>Annal D. Meleth, Veena R. Raiji, Nupura Krishnadev, and Emily Y. Chew</p><p>Chapter 6</p><p>Management of Neovascular AMD</p><p>Fernando M. Penha and Philip J. Rosenfeld</p><p>Chapter 7</p><p>Combination Therapy with Ocular Photodynamic Therapy for Age-Related Macular Degeneration<br/>Nathan Steinle and Peter K. Kaiser</p><p>Chapter 8</p><p>The Future of Non-Neovascular (Dry) Age-Related Macular Degeneration</p><p>Ketan Laud, Sri Krishna Mukkamala, Claudia Brue, and Jason S. Slakter</p><p>Chapter 9</p><p>The Future of Neovascular Age-Related Macular Degeneration</p><p>Chirag P. Shah and Jeffrey S. Heier</p><p>Chapter 10</p><p>The Economics of Age-Related Macular Degeneration</p><p>Gary C. Brown, Melissa M. Brown, Heidi B. Lieske, Philip A. Lieske, and Kathryn Brown<p><p>Genetics of Age-Related Macular Degeneration</p><p>Daniel Kasuga, Yuhong Chen, and Kang Zhang</p><p>Chapter 2</p><p>Modifiable Risk Factors of Age-Related Macular Degeneration</p><p>Hanna R. Coleman</p><p>Chapter 3</p><p>Diagnosis of Age-Related Macular Degeneration</p><p>Jon Jonisch and Gaurav Shah</p><p>Chapter 4</p><p>Fundus Imaging of Age-Related Macular Degeneration</p><p>Allen Chiang, Andre J. Witkin, Carl D. Regillo, and Allen C. Ho</p><p>Chapter 5</p><p>Therapy of Non-Exudative Age-Related Macular Degeneration</p><p>Annal D. Meleth, Veena R. Raiji, Nupura Krishnadev, and Emily Y. Chew</p><p>Chapter 6</p><p>Management of Neovascular AMD</p><p>Fernando M. Penha and Philip J. Rosenfeld</p><p>Chapter 7</p><p>Combination Therapy with Ocular Photodynamic Therapy for Age-Related Macular Degeneration<br>Nathan Steinle and Peter K. Kaiser</p><p>Chapter 8</p><p>The Future of Non-Neovascular (Dry) Age-Related Macular Degeneration</p><p>Ketan Laud, Sri Krishna Mukkamala, Claudia Brue, and Jason S. Slakter</p><p>Chapter 9</p><p>The Future of Neovascular Age-Related Macular Degeneration</p><p>Chirag P. Shah and Jeffrey S. Heier</p><p>Chapter 10</p><p>The Economics of Age-Related Macular Degeneration</p><p>Gary C. Brown, Melissa M. Brown, Heidi B. Lieske, Philip A. Lieske, and Kathryn Brown</p></p></p><p>Genetics of Age-Related Macular Degeneration</p><p>Daniel Kasuga, Yuhong Chen, and Kang Zhang</p><p>Chapter 2</p><p>Modifiable Risk Factors of Age-Related Macular Degeneration</p><p>Hanna R. Coleman</p><p>Chapter 3</p><p>Diagnosis of Age-Related Macular Degeneration</p><p>Jon Jonisch and Gaurav Shah</p><p>Chapter 4</p><p>Fundus Imaging of Age-Related Macular Degeneration</p><p>Allen Chiang, Andre J. Witkin, Carl D. Regillo, and Allen C. Ho</p><p>Chapter 5</p><p>Therapy of Non-Exudative Age-Related Macular Degeneration</p><p>Annal D. Meleth, Veena R. Raiji, Nupura Krishnadev, and Emily Y. Chew</p><p>Chapter 6</p><p>Management of Neovascular AMD</p><p>Fernando M. Penha and Philip J. Rosenfeld</p><p>Chapter 7</p><p>Combination Therapy with Ocular Photodynamic Therapy for Age-Related Macular Degeneration<br>Nathan Steinle and Peter K. Kaiser</p><p>Chapter 8</p><p>The Future of Non-Neovascular (Dry) Age-Related Macular Degeneration</p><p>Ketan Laud, Sri Krishna Mukkamala, Claudia Brue, and Jason S. Slakter</p><p>Chapter 9</p><p>The Future of Neovascular Age-Related Macular Degeneration</p><p>Chirag P. Shah and Jeffrey S. Heier</p><p>Chapter 10</p><p>The Economics of Age-Related Macular Degeneration</p><p>Gary C. Brown, Melissa M. Brown, Heidi B. Lieske, Philip A. Lieske, and Kathryn Brown<p><p>Genetics of Age-Related Macular Degeneration</p><p>Daniel Kasuga, Yuhong Chen, and Kang Zhang</p><p>Chapter 2</p><p>Modifiable Risk Factors of Age-Related Macular Degeneration</p><p>Hanna R. Coleman</p><p>Chapter 3</p><p>Diagnosis of Age-Related Macular Degeneration</p><p>Jon Jonisch and Gaurav Shah</p><p>Chapter 4</p><p>Fundus Imaging of Age-Related Macular Degeneration</p><p>Allen Chiang, Andre J. Witkin, Carl D. Regillo, and Allen C. Ho</p><p>Chapter 5</p><p>Therapy of Non-Exudative Age-Related Macular Degeneration</p><p>Annal D. Meleth, Veena R. Raiji, Nupura Krishnadev, and Emily Y. Chew</p><p>Chapter 6</p><p>Management of Neovascular AMD</p><p>Fernando M. Penha and Philip J. Rosenfeld</p><p>Chapter 7</p><p>Combination Therapy with Ocular Photodynamic Therapy for Age-Related Macular Degeneration<br>Nathan Steinle and Peter K. Kaiser</p><p>Chapter 8</p><p>The Future of Non-Neovascular (Dry) Age-Related Macular Degeneration</p><p>Ketan Laud, Sri Krishna Mukkamala, Claudia Brue, and Jason S. Slakter</p><p>Chapter 9</p><p>The Future of Neovascular Age-Related Macular Degeneration</p><p>Chirag P. Shah and Jeffrey S. Heier</p><p>Chapter 10</p><p>The Economics of Age-Related Macular Degeneration</p><p>Gary C. Brown, Melissa M. Brown, Heidi B. Lieske, Philip A. Lieske, and Kathryn Brown</p></p><p><p>Genetics of Age-Related Macular Degeneration</p><p>Daniel Kasuga, Yuhong Chen, and Kang Zhang</p>Chapter 2</p><p>Modifiable Risk Factors of Age-Related Macular Degeneration</p><p>Hanna R. Coleman</p><p>Chapter 3</p><p>Diagnosis of Age-Related Macular Degeneration</p><p>Jon Jonisch and Gaurav Shah</p><p>Chapter 4</p><p>Fundus Imaging of Age-Related Macular Degeneration</p><p>Allen Chiang, Andre J. Witkin, Carl D. Regillo, and Allen C. Ho</p><p>Chapter 5</p><p>Therapy of Non-Exudative Age-Related Macular Degeneration</p><p>Annal D. Meleth, Veena R. Raiji, Nupura Krishnadev, and Emily Y. Chew</p><p>Chapter 6</p><p>Management of Neovascular AMD</p><p>Fernando M. Penha and Philip J. Rosenfeld</p><p>Chapter 7</p><p>Combination Therapy with Ocular Photodynamic Therapy for Age-Related Macular Degeneration<br>Nathan Steinle and Peter K. Kaiser</p><p>Chapter 8</p><p>The Future of Non-Neovascular (Dry) Age-Related Macular Degeneration</p><p>Ketan Laud, Sri Krishna Mukkamala, Claudia Brue, and Jason S. Slakter</p><p>Chapter 9</p><p>The Future of Neovascular Age-Related Macular Degeneration</p><p>Chirag P. Shah and Jeffrey S. Heier</p><p>Chapter 10</p><p>The Economics of Age-Related Macular Degeneration</p><p>Gary C. Brown, Melissa M. Brown, Heidi B. Lieske, Philip A. Lieske, and Kathryn Brown</p>